Clinical Trials Logo

Clinical Trial Summary

This project will test the accuracy of a novel diffusion-weighted magnetic resonance imaging (DWMRI) approach using a deep convolutional neural network (DCNN) to predict an optimal resection margin for pediatric epilepsy surgery objectively. Its primary goal is to minimize surgical risk probability (i.e., functional deficit) and maximize surgical benefit probability (i.e., seizure freedom) by precisely localizing eloquent white matter pathways in children and adolescents with drug-resistant focal epilepsy. This new imaging approach, which will acquire a DWMRI scan before pediatric epilepsy surgery in about 10 minutes without contrast administration (and also without sedation even in young children), can be readily applied to improve preoperative benefit-risk evaluation for pediatric epilepsy surgery in the future. The investigators will also study how the advanced DWMRI-DCNN connectome approach can detect complex signs of brain neuronal reorganization that help improve neurological and cognitive outcomes following pediatric epilepsy surgery. This new imaging approach could benefit targeted interventions in the future to minimize neurocognitive deficits in affected children. All enrolled subjects will undergo advanced brain MRI and neurocognitive evaluation to achieve these goals. The findings of this project will not guide any clinical decision-making or clinical intervention until the studied approach is thoroughly validated.


Clinical Trial Description

This project will combine advanced brain MRI with detailed neuro-psychology evaluation, performed in children and adolescents affected by drug-resistant focal epilepsy, to address two main aims, each of them with the following research hypotheses: AIM 1. To determine the accuracy of deep learning tractography-based benefit-risk analysis compared to a standard electrical stimulation mapping (ESM) which is the current clinical standard for detecting eloquent cortical regions before epilepsy surgery. Hypothesis 1.1 In healthy controls, DCNN-based tract classification will localize eloquent cortices, which are significantly overlapped at both single shell DWI acquisition and generalized Q-sampling imaging, suggesting that the accuracy of this approach may not be significantly affected by the acquisition protocol. Hypothesis 1.2 DCNN-based tract classification will achieve at least 93% accuracy for prospective detection of ESM-defined eloquent cortices, including patients with a high likelihood of functional reorganization. Hypothesis 1.3 Preservation of DCNN-classified eloquent white matter pathways during surgery will predict the avoidance of postoperative deficits as accurately as the preservation of ESM-defined eloquent cortex. Hypothesis 1.4 Preservation of surgical margins optimized by Kalman filter on retrospective data will achieve seizure control and avoidance of postoperative deficits in a prospective surgical patient cohort. In this aim, the investigators will test the accuracy of a recently developed deep learning-based benefit-risk model, called deep convolutional neural network (DCNN) tract classification combined with Kalman filter analysis, for non-invasive detection of eloquent white matter pathways and optimization of surgical margin (i.e., the distance between epileptogenic area and eloquent area), resulting in seizure freedom and avoidance of functional deficits. Failure to identify eloquent areas in the proposed resection region can have potentially lifelong consequences, and overestimation or incorrect localization of the extent of the eloquent regions may lead to incomplete resection of the epileptogenic zone. Without optimizing the benefit-risk ratio, the minimum acceptable margin is highly variable across different settings, ranging from 0 to 2 cm across epilepsy surgery centers. The investigators will study whether the proposed benefit-risk model can standardize (or customize) epilepsy surgery of individual patients by accurately optimizing the margins of the eloquent white matter pathways to be preserved, which is ultimately essential to balance the benefit of seizure freedom with the risk of functional deficit. This proposed new imaging approach could change clinical practice for pediatric epilepsy surgery and is widely applicable for other types of neurosurgical procedures such as tumor resection. AIM 2. To determine the accuracy of deep learning-based connectome analysis for prediction of long-term neurocognitive improvement following epilepsy surgery. Hypothesis 2.1 Connectivity efficiencies preserved in specific modular networks of preoperative DCNN-based connectome, found to be associated with postoperative functional improvement on retrospective data, will accurately predict long-term functional improvement in a prospective patient cohort. Hypothesis 2.2 Longer epilepsy duration will be significantly associated with more decreased efficiency in full-scale IQ modular network of preoperative DCNN-based connectome, thus suggesting that earlier surgery will yield better long-term full-scale IQ improvement. Hypothesis 2.3 Patients with ipsilateral resections, who show signs of postoperative "crowding" (i.e., verbal IQ improvement at the expense of non-verbal function), will show decreased efficiency in non-verbal and increased efficiency in verbal IQ network of DCNN-based connectome in the contralateral hemisphere. In this aim, the investigators will test if an advanced DWMRI approach integrating DCNN and connectome helps decide timely surgery by providing 1) preoperative imaging markers underlying high likelihood of postoperative neurocognitive improvements and 2) mechanistic insight in structural brain reorganization associated with postoperative verbal IQ improvement. A series of preoperative imaging markers called "local efficiency" that quantifies how efficiently neural connection is shared by neighboring regions will be evaluated at the levels of specific modular networks. We expect that these markers can identify long-term and specific neurocognitive consequences (and potential predictors of these) associated with surgical intervention and their neural correlates for specific neurocognitive functions. In addition, neuronal remodeling associated with a functional crowding effect, studied with DWMRI connectome improved by the DCNN tract classification, will provide a new mechanistic insight in compensatory processes for verbal IQ function in children and adolescents who undergo resective surgery to treat drug-resistant focal epilepsy. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04986683
Study type Interventional
Source Wayne State University
Contact Justin J Jeong, PhD
Phone 313-993-0258
Email jjeong@med.wayne.edu
Status Recruiting
Phase N/A
Start date August 1, 2021
Completion date June 30, 2026

See also
  Status Clinical Trial Phase
Recruiting NCT02245061 - Cortical Excitability Assessment Using Paired Pulses N/A
Terminated NCT05081518 - A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy Phase 1
Withdrawn NCT05481905 - ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures Phase 2
Completed NCT02208492 - The Effects on Cognitive Function of Levetiracetam (Keppra®) Compared to Carbamazepine (Tegretol®, Carmazepine®) as Monotherapy for Children With Partial Seizure; A Multicentric Randomized Controlled Study Phase 4
Recruiting NCT04839601 - RNS System RESPONSE Study N/A
Completed NCT02898935 - Improvement of the Accuracy of Spatial Representation of Invasive Exploratory Electrodes in Focal Epilepsy
Enrolling by invitation NCT05748236 - The Efficacy and Safety of Lamotrigine Versus Carbamazepine in Focal Epilepsy Phase 4
Terminated NCT01724918 - Lacosamide IV and EEG/EKG (LIVE) Study Phase 2
Completed NCT00855738 - A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice Phase 4
Not yet recruiting NCT06210022 - Cognitive Impairment in Drug-resistant and Drug-responsive Focal Cryptogenic Epilepsy
Completed NCT01311440 - Modified Atkins Diet Treatment for Adults With Drug-resistant Epilepsy N/A
Terminated NCT03955432 - Long-term Cardiac Monitoring in Epilepsy N/A
Recruiting NCT06132893 - A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Phase 2/Phase 3
Recruiting NCT05100771 - Optimized Volumetry in Radiology: Interest in Pediatric Brain MRI in the Exploration of Focal Epilepsy
Recruiting NCT04879433 - Prospective Open-label Evaluation of Cenobamate Adjunctive Treatment of Adults With Refractory Focal Epilepsy
Active, not recruiting NCT03916848 - Novel Network Analysis of Intracranial Stereoelectroencephalography N/A
Recruiting NCT05198882 - Clinical Evaluation of Interstitial Laser Thermal Therapy Under Continuous MRI Monitoring as a Minimally Invasive Treatment of Patients With Medically Unbalanced Partial Epilepsy Phase 1
Recruiting NCT05981755 - Breathing Rescue for SUDEP Prevention N/A
Recruiting NCT03457961 - Post-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong Kong
Completed NCT03082222 - ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions